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Protocol
AbstrACt
Introduction Despite advances in infection prevention 
and control, catheter-associated urinary tract infections 
(CAUTIs) are common and remain problematic. Prolonged 
urinary catheterisation is the main risk factor for 
development of CAUTIs; hence, interventions that target 
early catheter removal warrant investigation. The study’s 
objectives are to examine the efficacy of an electronic 
reminder system, the CATH TAG, in reducing urinary 
catheter use (device utilisation ratio) and to determine the 
effect of the CATH TAG on nurses’ ability to deliver patient 
care.
Methods and analysis This study uses a mixed methods 
approach in which both quantitative and qualitative 
data will be collected. A stepped wedge randomised 
controlled design in which wards provide before and after 
observations will be undertaken in one large Australian 
hospital over 24 weeks. The intervention is the use of 
the CATH TAG. Eligible hospital wards will receive the 
intervention and act as their own control, with analysis 
undertaken of the change within each ward using data 
collected in control and intervention periods. An online 
survey will be administered to nurses on study completion, 
and a focus group for nurses will be conducted 2 months 
after study completion. The primary outcomes are the 
urinary catheter device utilisation ratio and perceptions 
of nurses about ease of use of the CATH TAG. Secondary 
outcomes include a reduced number of cases of catheter-
associated asymptomatic bacteriuria, a reduced number 
of urinary catheters inserted per 100 patient admissions, 
perceptions of nurses regarding effectiveness of the CATH 
TAG, changes in ownership/interest by patients in catheter 
management, as well as possible barriers to successful 
implementation of the CATH TAG.
Ethics and dissemination Approval has been obtained 
from the Human Research Ethics Committees of Avondale 
College of Higher Education (2017:15) and Queensland 
Health (HREC17QTHS19). Results will be disseminated via 
peer-reviewed journals and conference presentations.
trial registration number ACTRN12617001191381 (Pre-
results).
IntroduCtIon
Urinary tract infections (UTIs) are 
one of the most frequently reported 
healthcare-associated infections globally.1–3 
The majority of healthcare-associated urinary 
tract infections (HAUTIs) are related to 
urinary catheters, which are estimated to be 
placed in up to 26% of patients admitted to 
hospitals.4 HAUTIs, including catheter-as-
sociated urinary tract infections (CAUTIs), 
are associated with increased morbidity 
and mortality and prolonged hospital 
stay.5 6 Furthermore, they are associated 
with higher risk of antimicrobial resistance, 
which complicates treatment.7–10 In addi-
tion to their clinical consequences, CAUTIs 
are costly to patients and health systems. In 
the USA, symptomatic episodes of CAUTIs 
may add an estimated US$1200–US$4700 to 
patient costs.3 In Australia, hospital-acquired 
UTIs were estimated to contribute an addi-
tional cost of $A24.7 million to the hospital 
system.11 An estimated 380 000 infections and 
9000 deaths attributed to CAUTIs each year 
may be preventable through the use of effec-
tive infection prevention and control strate-
gies.3 However, despite advances in infection 
prevention and control, CAUTIs remain 
problematic,12 hence further research is 
needed to identify ways to reduce the burden 
they create.4 13–16 
strengths and limitations of this study
 ► This is the first study to investigate the use of a novel 
electronic device as a reminder intervention to re-
duce urinary catheter use and the burden of cathe-
ter-associated urinary tract infections.
 ► Stepped wedge randomised controlled design max-
imises feasibility and statistical power.
 ► Minimal risk for participants.
 ► Results that will inform infection prevention and 
control practice and guidelines internationally.
 ► Data collection is limited to one Australian hospital.
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Prolonged urinary catheterisation has been identi-
fied as the greatest risk factor for CAUTIs.16 Indwelling 
urinary catheters are often placed unnecessarily, lack 
documented reasons for insertion and are not promptly 
removed when no longer warranted.16 A national study 
of US hospitals that examined current practices used by 
hospitals to prevent HAUTIs found that 56% of hospitals 
did not have a system for monitoring which patients had 
urinary catheters placed and 75% did not monitor cath-
eterisation duration.17 When a urinary catheter remains 
in situ, the daily risk of acquiring bacteriuria is estimated 
to range from 3% to 7%.18 An intervention that prompts 
removal of catheters at the earliest opportunity when 
they are no longer medically indicated should therefore 
be an effective method for reducing urinary catheterisa-
tion duration and preventing subsequent development of 
CAUTIs.19
Maintaining awareness of the continued presence of 
urinary catheters is a key step towards initiating prompt 
removal of catheters as healthcare staff may be unaware 
of the catheters’ existence.20 Hence, interventions 
that promote frequent reminders about catheters are 
needed. A reminder intervention is a mechanism used to 
remind either a physician or nurse that the catheter is 
still in place and that removal may be warranted if the 
catheter is no longer required.16 A systematic review and 
meta-analysis that evaluated the effect of urinary catheter 
reminder systems on urinary catheter use and CAUTI 
rates was published in 201016 and updated in 2013.20 In 
both reviews, the benefit of reminder systems in reducing 
urinary catheter use and CAUTIs was demonstrated. 
Catheter reminder interventions evaluated in these 
studies included verbal or written reminders, a sticker on 
the catheter bag or patient’s chart, computer-generated 
reminders or stop orders.16 20 However, no studies investi-
gating the use of an electronic device as a reminder inter-
vention were identified.
The frequency of unnecessary and prolonged catheter 
use, subsequent increase in the risk of CAUTIs, along 
with its clinical and financial implications in Australia and 
worldwide, provide a strong rationale for a novel method 
to reduce urinary catheter use and the burden of CAUTIs. 
To date, in Australia, there is limited research on inter-
ventions aimed at reducing urinary catheter use with no 
rigorously designed studies undertaken. Addressing this 
gap in knowledge, the two main objectives of the present 
study are to: (1) examine the efficacy of an electronic 
reminder system, the CATH TAG, to reduce the urinary 
catheter device utilisation ratio in hospitalised patients 
and (2) to determine whether the CATH TAG has an 
effect on nurses’ ability to deliver patient care.
MEthods
study design
A mixed methods approach will be used, including both 
quantitative and qualitative data collection. For quan-
titative data collection, a stepped wedge randomised 
controlled design in which clusters provide before and 
after observations21 will be undertaken in one hospital 
over a 24-week period (figure 1). The clusters in the 
study are individual hospital wards. The design includes 
an initial baseline period where no wards are exposed to 
the intervention.21 Subsequently, at regular intervals, two 
wards forming two clusters will cross over from the control 
phase to the intervention with the process continuing 
until all enrolled wards have crossed over.21 There will be 
a random sequential allocation of the intervention to the 
wards, that is, each enrolled ward will be introduced to the 
intervention two at a time, approximately every 4 weeks 
until week 20, when all wards would have been exposed 
to the intervention. The study design enables each ward 
to act as its own control, which mitigates the potential 
for some confounders such as variations in ward size and 
case mix. Staggered commencement and duration of 
the intervention supports feasibility while maintaining 
the rigour of the study.22 This design will allow research 
staff to work with individual wards as they change over, 
maximising consistency of the intervention and aiding 
implementation.22 In addition, data collection continues 
throughout the study, so that each cluster contributes 
observations under both control and intervention obser-
vation periods. In month 6 of the study, qualitative data 
will be collected through an online survey administered 
Figure 1 Study design overview. Blue=control phase; green=intervention phase.
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to nursing staff. Approximately 2 months after the study 
is completed, a focus group comprising nurses will be 
conducted to obtain additional qualitative data about the 
nurses’ perceptions of how the CATH TAG was used in 
practice.
study setting
One Australian hospital with an intensive care unit and 
over 30 000 patient admissions per year will be enrolled 
in the study using convenience sampling.
recruitment of hospital
The recruitment process will purposively invite eligible 
hospitals to participate through stakeholder and partner 
networks. The first confirmed hospital will be accepted.
Ward-level inclusion and exclusion criteria
1. Potential wards and units eligible for inclusion are 
medical wards, surgical wards and intensive care units.
2. Day-stay units and psychiatric wards will be excluded.
Patient-level inclusion and exclusion criteria
1. All patients in eligible wards of the hospital who have 
an indwelling urinary catheter administered as part of 
their usual clinical care will be included.
2. Neonates (<2 years old) may be excluded if the CATH 
TAG is too large for the catheter bag or interferes with 
patient care.
Intervention
The intervention is the use of the CATH TAG (figure 2). 
The CATH TAG is an electronic device in the form of 
a sticker that adhesively attaches to the catheter bag. It 
weighs approximately 5 g and has a non-intrusive green 
light that flashes intermittently for a period of 24 hours 
on activation. After 24 hours, the green flashing light 
changes to red, flashing with increased rapidity and visi-
bility. The light will flash red for 4 hours and subsequently 
change back to green, slower flashing, restarting the 
cycle. The red flashing light is an indication for the nurse 
to reassess the need for a urinary catheter and remove it 
if no longer required. This cycle will continue for 10 days 
and then change permanently to the red flashing light to 
indicate that the battery of the CATH TAG is exhausted. 
There is no option for nurses to manipulate the flashing 
light or amend the flashing cycle.
Implementing the intervention
Randomisation and blinding
Eligible wards in the hospital will be randomly assigned to 
cross over to the intervention every 4 weeks over the trial 
duration of 24 weeks. If no clustering, the sample size for 
80% power at 0.05 significance would be 816. Allocation 
of wards to the intervention will be concealed. Comput-
er-generated randomisation of the crossover dates for 
the wards will be performed independently by one of the 
investigators, who will not be involved in assessment or 
delivery of the intervention. All included wards will be 
provided with sufficient notice of the dates to cross over 
to the intervention. Wards will not be blinded, because it 
is not feasible to blind staff to the intervention.
Implementation
In the week prior to the intervention commencing, infor-
mation sessions about the study will be provided to the 
participating hospital and staff. A variety of methods will 
be used to further alert staff and raise awareness about the 
intervention prior to it being rolled out. These methods 
include placing wall posters in wards and key locations, 
handing out flyers and information leaflets as well as 
branded promotional material, such as pens. Nurses will 
be trained to use the CATH TAG.
Control phase
During the control phase, usual practice regarding cath-
eter care and removal will occur, according to local policy 
or process guidelines. No electronic or alert systems for 
catheter removal will be used.
Intervention phase
Every 4 weeks, after an initial control phase with no inter-
vention, two wards will cross over to the intervention. 
With commencement of the intervention on the ward, a 
CATH TAG will be attached to every urinary catheter bag.
Figure 2 The CATH TAG attached to a catheter bag.
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For patients who are transferred from a control ward 
to an intervention ward, a CATH TAG will be attached to 
their urinary catheter on transfer. For patients who are 
transferred from an intervention ward to a control ward, 
the CATH TAG will be removed on transfer.
When a ward transitions to the intervention, a CATH 
TAG will be attached to all new catheter insertions. This 
includes transfers of patients with a urinary catheter to 
the transitioning ward. Patients who had a urinary cath-
eter inserted before the transition date will not receive 
a CATH TAG on their urinary catheter bag to prevent 
non-independence of observations and to increase feasi-
bility of the implementation of the intervention in the 
hospital. Their data will contribute to the control group 
data set.
outcome measures
The outcomes for each objective of the study are outlined 
in table 1.
definitions
Catheter-associated asymptomatic bacteriuria (CA-ASB) 
is defined as the presence of ≥105 colony forming unit 
(cfu)/mL of ≥1 bacterial species in a single catheter urine 
specimen in a patient without symptoms compatible with 
UTI.23
data collection
Urinary catheter data
Data will be collected by an appointed staff member at 
the hospital, supported by the research team. If data 
collection results in increased workload for the hospital 
staff, the research team will provide additional resources 
in the form of funding to cover additional hours for the 
staff member or employment of a second staff member 
for the purpose of data collection. For the purpose of this 
protocol, the hospital staff member(s) undertaking data 
collection will be referred to as hospital personnel. The 
research team will provide the hospital personnel with 
training about the project, data collection processes and 
data collection tools, as well as ongoing on-site and tele-
phone support. Figure 3 summarises the data collection 
process.
Hospital personnel will visit inpatient areas, and 
patients who receive an indwelling urinary catheter will 
be identified and followed up until discharge or cath-
eter removal. Hospital personnel will check that a CATH 
TAG has been attached to every catheter bag, on wards 
that have crossed over to the intervention. A review of 
medical notes and microbiology laboratory records will 
be undertaken by the hospital personnel for each patient 
who receives a catheter and has a urinary sample taken. 
Figure 3 Overview of data collection process.
Table 1 Key outcome measures
Objective Outcome Outcome measure
Objective 1
To determine the 
efficacy of an 
electronic reminder 
system in reducing 
urinary catheter 
use in hospitalised 
patients.
Primary outcome 1. Urinary catheter 
device utilisation 
ratio (number of 
urinary catheter-
days divided by the 
number of patient-
days).
Secondary 
outcomes
1. The number of 
cases of catheter-
associated 
asymptomatic 
bacteriuria (CA-
ASB) per 100 
catheter days.
2. The number of 
urinary catheters 
inserted per 100 
patient admissions.
Objective 2
To determine 
whether the CATH 
TAG has an effect 
on nurses’ ability to 
deliver patient care.
Primary outcome 1. Perceptions of 
nurses about ease 
of use of the CATH 
TAG.
Secondary 
outcomes
1. Perceptions 
of nurses about 
effectiveness of the 
CATH TAG.
2. Changes 
in ownership 
or interest by 
patients in catheter 
management.
3. Barriers to the 
CATH TAG working 
successfully in 
varied types of 
patients.
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Data to be collected at the time of visit of the hospital 
personnel to the ward include: hospital number, date 
and time of catheter insertion, date and time of catheter 
removal, use of CATH TAG (yes/no). Additional patient 
data collected include: age, sex, date of admission, reason 
for censoring follow-up, date and time of discharge or 
catheter removal, designation of person inserting the 
catheter and ward. If a patient has a positive urine culture 
after catheterisation and prior to removal, the following 
data will be collected: date of specimen collection, organ-
ism(s) isolated, cfus and white cell count. Online supple-
mentary file A provides a detailed list of types, sources 
and timing of data to be collected.
The number of catheter days for each patient included 
in the study will be estimated from the date and time 
of catheter insertion to the date and time of removal. 
Hospital personnel will record all captured data locally 
on a spreadsheet, designed by the research team specifi-
cally for the purpose of the study.
Survey data
Data collection will involve the use of a structured anon-
ymous survey administered using an online tool. Nurse 
participants will be asked a series of questions that relate 
to their perceptions about ease of use of the CATH 
TAG, their views on effectiveness of the CATH TAG, an 
exploration of their perceptions of change in owner-
ship or interest by patients in catheter management and 
any barriers to the CATH TAG working successfully that 
nurses might be experiencing, forming the following four 
dimensions, based on the objectives of the study:
 ► Ease of use.
 ► Effectiveness.
 ► Perceived changes in ownership regarding patients’ 
healthcare.
 ► Barriers.
Items exploring those dimensions will be presented to 
participants in the form of statements, to be answered on 
a 5-point Likert scale, as well as in the form of open ques-
tions and yes/no questions to investigate possible themes 
for the focus group.
Additionally, demographic information about the 
participants will be collected, including the ward on which 
they primarily work, age, gender, years of nursing experi-
ence (postqualification) and their highest (completed) 
qualification. No identifiable or reidentifiable informa-
tion will be collected.
Focus group data
Participants in the focus group will be limited to approxi-
mately six to eight nurses to ensure the group can be run 
effectively. If required for the purposes of data saturation, 
a second focus group might be run to ensure representa-
tion from more wards. The focus group will be conducted 
in a location other than the ward on which the partic-
ipants work. A person with relevant training and expe-
rience will lead the group discussion. An exploration of 
experiences of the CATH TAG users will be undertaken 
using a series of questions to prompt discussion. The 
questions will be designed to validate the broad responses 
and themes received in the online survey and provide the 
opportunity for in-depth feedback not otherwise possible 
from the online survey.
The timing of this focus group is important. As this 
study adopted a staggered approach to implement the 
intervention, scheduling the focus group towards the end 
of the study will enable the researchers to capture the 
participants’ responses after staggered levels of involve-
ment in use of the CATH TAG.
To further understand the participants’ experience 
using the CATH TAG, the focus group questions will aim 
to capture information about the personal experiences of 
the hospital personnel and their construed perceptions of 
patients’ perceptions, regarding the use and effectiveness 
of the CATH TAG. The objective of the focus group is 
to acquire maximum in-depth feedback about the CATH 
TAG. In combination with the quantitative analysis of the 
survey data and the catheter data collected, gathering 
qualitative data by conducting a focus group contributes 
to a more holistic measure of the experience of the CATH 
TAG. In so doing, we considered the end-user perspec-
tive. The focus group provides the researchers with the 
unique opportunity to receive suggestions for improve-
ment of the CATH TAG based on the participants’ expe-
riences. Participants will be asked to provide responses to 
questions about the following issues, including both their 
own perceptions about use of the CATH TAG as well as 
their construed perceptions of patients’ response to its 
use:
 ► Perceived ease of use of the CATH TAG.
 ► Perceived impact of the CATH TAG on patient care 
(effectiveness).
 ► Perceived impact on interactions with patients as a 
result of using the CATH TAG.
 ► Perceptions of patients’ experiences with, interest in 
and reactions to use of the CATH TAG.
 ► Perceptions of impact on patients’ ownership of their 
own healthcare as a result of using the CATH TAG.
 ► Perceived barriers to using the CATH TAG.
 ► Additional issues that emerge from analysis of the 
participants’ survey responses.
The focus group will be audio-recorded, with the 
permission of participants, to enable thematic analysis of 
the discussion at a later date. No identifiable or reidentifi-
able information provided during the focus group will be 
linked to any participant.
recruitment of participants for survey and focus group
Nurses have been chosen as the participants for the 
survey and focus group as they have the primary role in 
day-to-day urinary catheter management and care. In 
order to recruit nurses to participate in an online survey, 
information leaflets will be distributed to each partici-
pating ward during month 6 of the study. If approved by 
the hospital, the same information will be sent to nurses 
via email. Other communication methods such as a ward 
 o
n
 6 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020469 on 9 May 2018. Downloaded from 
6 Fasugba O, et al. BMJ Open 2018;8:e020469. doi:10.1136/bmjopen-2017-020469
Open Access 
communication diary, a reminder at a staff meeting or 
during handover may also be used.
The information leaflet/email will contain details 
about the survey and a web link (presented as a URL 
or alternatively as a QR code) to participate. Additional 
information regarding the study, in addition to a consent 
form, will be included at the beginning of the survey. To 
improve response rates, an incentive of 10 $A40 gift cards 
will be made available and will be allocated at random to 
those who complete the survey. To enter the draw for a 
gift card, participants will need to click on a separate web 
link provided at the end of the survey. This will ensure 
that no personal details are linked to the survey.
To recruit participants for a focus group, the partici-
pants will be provided with an opportunity to indicate 
their interest by registering their name at the end of the 
online survey by clicking on a separate web link. Again, 
this will ensure that no personal details are linked to the 
survey. Focus group participants will receive an $A80 gift 
card to compensate them for their time. If more nurses 
register for the focus group than are required, purposive 
sampling will occur to ensure a representative sample of 
different wards. If it remains such that there are still too 
many registered than can be enrolled, participants will 
be chosen at random within each representative sample 
group. The focus group will be conducted 2 months after 
completion of the intervention (the eighth month of the 
study). Prior to or on the day of the focus group, informa-
tion regarding the study will be provided, in addition to 
obtaining informed consent.
data monitoring and management
Data monitoring will be overseen by the chief investi-
gator, and the data monitoring committee consists of all 
investigators on the study. Data will be stored electron-
ically in a secure location at the administering institu-
tion. Data quality will be enhanced by the provision of 
a data collection form and quality checks by the project 
manager. A data collection guide has been developed to 
aide and document this process. Any approved changes 
to the study protocol will be updated in the Australia New 
Zealand Clinical Trial Registry.
sample size and power estimation
The population at risk has been defined as patients 
receiving urinary catheters in hospital. Based on pilot 
work, an estimated 25% of patients on admission will 
receive a catheter.4 We estimate that, at baseline, the 
median duration of catheterisation is 4 days (equivalent 
to a 50% probability that a catheter will be in situ on 
day 4).24 We aim to detect a difference of 20% relative 
risk (10% absolute risk) reduction in catheterisation on 
day 4 using a stepped wedge design.21 It is assumed the 
intraward correlation in catheter duration is ρ=0.1. Based 
on pilot work, it is anticipated that there will be 50 patients 
with a catheter per month on each ward, and the study 
will be for 6 months.4 A power calculation was performed 
using the stepped wedge module in Stata.25 This accounts 
for both the clustering in outcomes by ward, as well as the 
crossover design of the study.21 26
At a significance level of 0.05, 2100 patients (10 clusters 
(wards), with two clusters implementing the intervention 
at each month) will be required to demonstrate a change 
in the probability of a catheter being in situ on day 4 from 
50% to 40% with a power of 81%. Similar power would be 
expected with 35 patients with catheters per month in 10 
clusters, with two clusters implementing the intervention 
each month (n=2100, power 81%).
data analysis
Objective 1
Analysis will be by an intention-to-treat strategy, and this 
will involve inclusion of all patients in the randomised 
clusters in the analysis regardless of any deviations from 
the study protocol.27 Descriptive statistics will be used to 
summarise the characteristics of the study sample. Anal-
ysis will be performed using the generalised estimating 
equations, using the duration of catheterisation as the 
dependent variable and intervention as the independent 
variable. The confounding effect of calendar time on 
intervention exposure will be adjusted for in the anal-
ysis. We will consider time at risk for the control and 
intervention periods separately for patients present at 
the time of the crossover. The use of the analysis consid-
ering clustering at the ward level implicitly accounts for 
the non-independence of these patient observations. 
It is anticipated that duration of catheterisation will be 
log-normally distributed, but exploratory analyses (and 
where necessary transformation) will be performed. 
Robust SEs will be used to adjust for correlation at ward 
level and autocorrelation in time. There is no expected 
delay in the effect of the intervention on the outcome.
Analyses of secondary outcomes of the number of cases 
of CA-ASB per 100 catheter days and number of urinary 
catheters inserted per 100 patient admissions will also be 
undertaken, and these outcomes will be compared from 
data collected preintervention and postintervention. A 
sensitivity analysis will exclude the first month following 
implementation, and a subgroup analysis will consider 
medical and surgical wards separately.
Objective 2
Survey
Data from the online survey will be analysed quanti-
tatively using SPSS. It is anticipated that data will be 
normally distributed, but exploratory analyses will be 
performed, including testing of assumptions of linearity, 
homoscedasticity, multicollinearity and normality of 
errors and if necessary transformation of data. Validity 
and reliability of the survey will be assessed, as outlined 
in further detail below. During development of the 
survey items, experts have been consulted to ensure face 
validity. Construct validity will be measured by respec-
tively correlating nurses’ scores on three general items 
included in the survey for this purpose. To approach 
criterion validity, the predictive validity of the survey will 
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be assessed by comparing survey data with focus group 
data, that is, by predicting the attitude of nurses towards 
the CATH TAG in the focus group, based on nurses’ atti-
tudes towards the CATH TAG, measured by the survey. 
Reliability will be determined by calculating Cronbach’s 
α using SPSS. Subsequently, a general satisfaction score 
and individual satisfaction scores for the four dimen-
sions of nurses’ experiences with the CATH TAG (ease 
of use, effectiveness, changes in ownership and barriers) 
will be calculated. Regression analysis will be conducted 
to determine if the duration of the intervention or the 
ward that nurses primarily work on had an effect on 
nurses’ experiences with the CATH TAG. Any problems 
reported in the open questions will be taken into the 
focus group to be discussed and subsequently analysed 
qualitatively.
Focus group
Data gathered from the focus group will be managed using 
qualitative software (NVivo). The data analysis process 
will aim to identify and investigate both predetermined 
and emerging themes in the data. Each piece of qualita-
tive data will be systematically treated by being labelled 
with a meaningful code. The predetermined themes will 
be drawn from the broad responses to the open questions 
in the survey, as well as from the study’s objectives and 
will be reflected in the focus group questions. Further-
more, thematic analysis will be used to establish emerging 
themes in the qualitative data gathered during the focus 
group. This process of considering both predetermined 
and emergent themes reduces redundancy in the analysis 
results by collapsing similar themes, identifies any rela-
tionships between the themes and ensures saturation is 
achieved. In this way, the essence of the hospital person-
nel’s perceptions will be determined. Data saturation will 
be achieved when no new data, no new themes, no new 
coding and ability to replicate the study is achieved. One 
focus group is planned; however, a second will be under-
taken if required (to achieve saturation).
Patient and public involvement
Patients and/or public were not involved in the develop-
ment of this study protocol. However, patients’ perspec-
tives and interaction with the CATH TAG will be explored 
as part of the focus group.
EthICs And dIssEMInAtIon
Ethics
Any risks or harms associated with the study will 
be reported to the relevant human research ethics 
committee (HREC). Reporting of the study and progress, 
including any audits, will be conducted consistent with 
the requests of the HRECs who approved the study. Any 
modification to the study that has ethical implications will 
be forwarded to the HRECs for approval. Only the chief 
investigator and coinvestigators will have full authority to 
access the data collected. No identifiable or reidentifiable 
patient data will be collected by the investigators, thereby 
protecting anonymity and confidentiality of participants.
Informed consent
A waiver of individual patient consent has been obtained 
for this study from the relevant HRECs. No intervention 
is directly administered to patients, rather an addition 
to existing procedures regarding catheter removal is 
being undertaken. Consent will be obtained from partic-
ipants in both the online survey and focus group. Partic-
ipants undertaking the survey and/or focus group can 
withdraw their participation at anytime without being 
disadvantaged.
dissemination
Results will be published in peer-reviewed journals, 
presented at relevant conferences and communicated 
via professional networks. The study protocol has been 
presented at the 2017 Infection Prevention Society 
Conference, Manchester, UK and the 2017 Australasian 
College for Infection Prevention and Control Confer-
ence, Canberra, Australia.
dIsCussIon
Urinary catheters are important medical devices for 
patient management.28 However, unnecessary and 
prolonged use of these devices poses an important risk to 
patient safety as they have the potential to result in both 
infectious and non-infectious complications.29 30 There-
fore, interventions aimed at reducing urinary catheter use 
should be investigated. To our knowledge, this is the first 
randomised controlled study evaluating the effectiveness 
of a novel electronic reminder device, the CATH TAG, in 
reducing urinary catheter usage in hospitalised patients.
Confounders
Potential confounders include the effect from different 
staff inserting and caring for patients with an indwelling 
catheter and the indications for urinary catheterisation. 
The design of this study minimises many of these issues, 
as wards (clusters) act as their own control. Furthermore, 
there is no reason to suggest a fundamental change in the 
control and intervention periods for these variables. Given 
the potential for secular changes in the outcome due to 
the influence of external forces such as changes in health-
care delivery, calendar time might have a confounding 
effect on intervention exposure and will be adjusted for 
in the data analysis.31 A Hawthorne effect32 may occur 
from study awareness and impending rollout of the inter-
vention in each ward, thereby increasing diligence in 
catheter maintenance that may lead to possible ‘contami-
nation’ of the intervention. To reduce this potential bias, 
educational events and training on the use of the CATH 
TAG will be staggered and delivered to wards individually 
in the week prior to implementing the intervention. In 
addition, any change in the primary outcome in the lead 
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up to the intervention will be modelled and taken into 
account in the analysis.
Furthermore, nurses working on a casual basis or across 
wards have the potential to provide responses to the 
survey or focus group from a range of perspectives based 
on their experiences on different wards. To minimise this, 
the survey will focus the respondent to experiences in one 
particular area and obtain details about their exposure to 
working in different hospital wards or units.
strengths
The study is strengthened by the use of a stepped wedge 
randomised controlled design in which clusters provide 
before and after observations. This design has been found 
to be particularly useful in studies evaluating intervention 
effectiveness during routine implementation such as this 
study where the insertion of a urinary catheter is consid-
ered to be part of the usual care of the patient.33 The 
study design also improves feasibility and enables each 
individual ward to act as its own control, which removes 
the potential for some confounders such as variations in 
ward size and case mix. Furthermore, the stepped wedge 
design is useful in pragmatic research such as that under-
taken in this study where the researchers wish to gain a 
first estimate of the efficacy of the CATH TAG in a clinical 
setting, and staggered implementation of the interven-
tion is therefore appropriate.34
Limitations
Data collection is limited to one Australian hospital. 
There might be variations in hospital size and case mix 
that influence the effectiveness and feasibility of the 
CATH TAG.
trial status
The study team is finalising hospital recruitment. The 
trial is due to commence in late 2017.
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